ArticleCureus2025
Functional Abnormalities of the Endocrine System in Beta-Thalassemia Major Patients: Insights From a Hospital-Based Observational Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Beta-thalassemia major (BTM) predisposes children to several endocrine complications, primarily driven by iron overload and repeated transfusions. This study aimed to determine the prevalence, patterns, and risk factors of endocrine dysfunction among multi-transfused pediatric patients with BTM. Methods A hospital-based cross-sectional study was conducted at Rajendra Institute of Medical Sciences (RIMS), Ranchi, including 100 pediatric patients aged two to 14 years diagnosed with BTM. Clinical profiles, transfusion history, anthropometric parameters, and laboratory investigations, including HbA1c, thyroid profile, serum ferritin, ALP, calcium, phosphate, parathyroid hormone, and cortisol, were analyzed. Statistical tests were performed using IBM SPSS Statistics version 26, with p ≤ 0.05 considered significant. Results Endocrine disorders were highly prevalent: diabetes mellitus (14.6%), growth hormone deficiency (11.2%), hypothyroidism (9.8%), and hypoparathyroidism (6.3%). Mean HbA1c was 6.8 ± 1.2%, with significantly higher levels in patients with diabetes (p = 0.002), hypothyroidism (p = 0.035), and growth hormone deficiency (p = 0.018). Logistic regression showed that iron overload (p = 0.022), frequent transfusions (p = 0.059), and older age (>10 years) (p = 0.041) were major predictors of endocrine dysfunction, while chelation therapy did not show a strong protective effect (p = 0.072). Conclusion Multi-transfused BTM patients are at substantial risk of developing endocrine abnormalities due to cumulative iron overload and chronic transfusion exposure. Regular endocrine screening, optimized iron chelation, and individualized transfusion protocols are essential to prevent long-term metabolic and hormonal complications. Strengthening multidisciplinary care is crucial for improving growth, development, and overall outcomes in this vulnerable population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.